NCT06417307

Exercise Therapy on Mitochondrial Functions of Lymphocyte in Hemodialysis

Supervised Exercise Therapy on Mitochondrial Functions of Platelet and Lymphocyte in Patients With End-Stage Renal Disease on Hemodialysis
Chang Gung Memorial Hospital·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Hemodialysis Complication
Drug/Device/Intervention
Supervised exercise training
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Chang Gung Memorial Hospital
Location
Taoyuan, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2021
End date
Jul 31, 2024
Enrollment
180 participants
Primary outcome

Mitochondrial function of lymphocyte

Summary

To improve aerobic capacity, muscular function and health-related quality of life in patients
 with end-stage renal disease (ESRD), regular exercise is recommended. Supervised
 intradialytic exercise with moderate intensity is an available approach to maintain patients'
 safety and compliance, and enhance physiological adaptations effectively. The exercise
 training effects of mitochondrial functions of lymphocyte in ESRD patients, like respiratory
 capacity, bioenergetic status and thrombosis/immunological regulation remained unclear.
 
 Method: ESRD patients (anticipated n=180) would conduct supervised exercise training therapy
 for 3 days a week for 6 months in the hospital and 3 months at home. Cardiopulmonary exercise
 therapy would be performed before and after the intervention. A high resolution respirometer
 and a flow cytometer are used to determine the oxygen consumption rate/mitochondrial
 respiration in mitochondria and subtypes of lymphocyte, respectively.

ICD-10 classifications
Kidney dialysisOther dialysisCare involving dialysisMechanical complication of vascular dialysis catheterHaemoglobinuria due to haemolysis from other external causes
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06417307
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06417307 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung Memorial Hospital and is currently Recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 180 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.